PRGO
Perrigo Company plc
PRGO's outlook is improving, though it still trails on the overall score.
UNH
UnitedHealth Group Incorporated
UNH has the edge over PRGO overall, supported by stronger fundamentals and lower modeled downside.
PRGO Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Under pressure | |
| Weak |
PRGO's revenue is currently stable, but its profitability, cash flow and balance sheet are under pressure.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
PRGO PE Valuation
PRGO has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
PRGO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect PRGO's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
PRGO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.53 | — |
| Q3 2026 | -$12.77 | -$12.39 |
| Q2 2026 | -$12.52 | -$11.94 |
| Q1 2026 | -$13.11 | -$11.80 |
| Q4 2025 | -$10.29 | -$9.04 |
| Q3 2025 | -$0.38 | +$0.78 |
| Q2 2025 | -$0.58 | +$0.33 |
| Q1 2025 | -$1.31 | -$1.25 |
| Q4 2024 | -$1.25 | -$1.16 |
PRGO lost $12.77 per share over the past year, a bigger loss than the year before.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over PRGO on earnings quality, reporting a profit while its opponent remains loss making.
PRGO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $988.6M | -5.2% |
| Q2 2026 | $1B | -3.2% |
| Q1 2026 | $969.2M | -7.2% |
| Q4 2025 | $1.1B | -2.5% |
| Q3 2025 | $1B | -4.1% |
| Q2 2025 | $1.1B | -0.9% |
| Q1 2025 | $1B | -3.5% |
| Q4 2024 | $1.1B | -1.6% |
PRGO's revenue has slid since its 2020 peak: $989M last quarter, down 5.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.3% | -4.6 points |
| Q2 2026 | 2.3% | -2 points |
| Q1 2026 | -38% | -43 points |
| Q4 2025 | -116% | -126 points |
| Q3 2025 | 7% | -0.4 points |
| Q2 2025 | 4.3% | +6.8 points |
| Q1 2025 | 4.5% | +9.6 points |
| Q4 2024 | 10% | +11 points |
PRGO's operating margin was 2.3% last quarter, down 4.6 points from the same quarter a year ago.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH has the edge over PRGO on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH has the edge over PRGO on profitability, with a higher operating margin.
PRGO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $78.7M | +164% |
| Q2 2026 | $68.3M | +20% |
| Q1 2026 | -$127.4M | -$37.4M |
| Q4 2025 | $148.6M | -46% |
| Q3 2025 | $29.8M | +97% |
| Q2 2025 | $56.7M | +$75.6M |
| Q1 2025 | -$90M | -$63.5M |
| Q4 2024 | $274.9M | +51% |
PRGO still generates free cash flow, though less than at its 2021 peak: $168M over the past year.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH still generates free cash flow, though less than at its 2022 peak: $22.8B over the past year.
PRGO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -200K shares |
| 1 year | +0.4% | +500K shares |
| 3 years | +1.8% | +2.5M shares |
| 5 years | +4.2% | +5.6M shares |
| Available history | +1.8% | +2.4M shares |
PRGO has 139M diluted shares, about the same as a year ago.
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over PRGO on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
PRGO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2025 | 5.3x | High |
| Q2 2025 | 5.2x | High |
| Q1 2025 | 6.0x | High |
| Q4 2024 | 7.0x | High |
| Q3 2024 | 10.5x | High |
| Q2 2024 | 11.5x | High |
| Q1 2024 | 8.5x | High |
| Q4 2023 | 6.5x | High |
PRGO's net debt is about 5.3 years of its operating earnings (EBITDA), down from 10 years a year ago.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
PRGO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 61.8 | Neutral |
| Stochastic | 84.4 | Overbought |
PRGO's weekly RSI is 62 (neutral) and its Stochastic is 84 (overbought).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
PRGO PE vs Healthcare Sector
| Metric | PRGO | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
PRGO has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
PRGO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $15.6 | 3.5% above |
| 20 week MA | $13.7 | 18% above |
| 50 week MA | $12.8 | 26% above |
| 100 week MA | $18.5 | 13% below |
| 200 week MA | $24.9 | 35% below |
PRGO has bounced recently, but its long-term trend is still down: it's above its 8-, 20- and 50-week averages, but 35% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over PRGO on trend strength, trading above more of its moving averages.
PRGO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.9 | $44.0 | -15% |
| 2021 | $44.0 | $39.5 | -10% |
| 2022 | $39.5 | $33.0 | -16% |
| 2023 | $33.0 | $32.2 | -2.5% |
| 2024 | $32.2 | $25.6 | -20% |
| 2025 | $25.6 | $13.8 | -46% |
| 2026 YTD | $13.8 | $16.2 | +17% |
PRGO has finished every year since 2020 lower, and it's up 17% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over PRGO on returns for 2026, with the stronger performance.